Загрузка...
Cabozantinib for progressive metastatic medullary thyroid cancer: a review
Medullary thyroid cancer is uncommon and patients typically present with advanced disease. Treatment options for patients with progressive, metastatic medullary thyroid cancer had been limited until recently. Tyrosine kinase inhibitors have garnered increasing interest in this subset of patients. Th...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4043815/ https://ncbi.nlm.nih.gov/pubmed/24920914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S46041 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|